IP Library Granted Patent US 8,679,482
Granted Patent B2
US 8,679,482 · App. 11/947,952 · Granted Mar 25, 2014

Method of promoting healing of a tympanic membrane perforation using plasminogen

Inventors: Tor Ny (Umea, SE); Jinan Li (Umea, SE); Sten Hellstrom (Umea, SE); Per-Olof Eriksson (Umea, SE)
Assignee: Omnio Healer AB
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,679,482
App. No.
11/947,952
Granted
Mar 25, 2014
Kind
B2
Abstract

The present invention relates to the use of plasminogen and plasmin as agents for enhancing healing of tympanic membrane perforations or other wounds, and for reducing scars or necrotic tissue forming during wound healing. The invention also relates to a method for screening of compounds which enhance wound healing by evaluating the healing of tympanic membrane perforations in an animal model.

Claims (9)

1. A method of promoting healing of a tympanic membrane perforation, comprising administering to a subject in need of such treatment a composition containing plasminogen, wherein the plasminogen is an amount effective to promote healing of the tympanic membrane perforation, and wherein the administration is by topical administration or by local injection.

2. The method of claim 1 , wherein the subject is a human, and the plasminogen is human plasminogen.

3. The method of claim 1 , wherein the composition further comprises a pharmaceutically acceptable carrier.

4. The method of claim 3 , wherein the composition is selected from a member selected from the group consisting of an aqueous solution, a gel, a lotion, a balm, a powder, a paste, a bandage, or a wound dressing.

5. The method of claim 4 , wherein the composition is administered by a spray.

6. The method of claim 1 , wherein the amount of plasminogen is from about 0.05 mg to about 10 mg plasminogen.

7. The method of claim 1 , wherein the amount of plasminogen is from about 0.5 to about 5 mg plasminogen.

8. The method of claim 1 wherein the amount of plasminogen is from about 5 μg to about 50 mg plasminogen.

9. The method of claim 1 , wherein the administration is by local injection.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 20, 2018
From: OMNIO HEALER AB (ORG NO. 556707-5006)
To: WYF INNOVATION UMEÅ AB
Reel/Frame 046416/0509 →
CHANGE OF NAME Recorded Jul 20, 2018
From: WYF INNOVATION UMEÅ AB
To: OMNIO HEALER UMEÅ AB
Reel/Frame 046416/0558 →
CHANGE OF NAME Recorded Jul 20, 2018
From: OMNIO HEALER UMEÅ AB
To: OMNIO HEALER AB (ORG NO. 556861-7863)
Reel/Frame 046416/0566 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2013
From: NY, TOR; LI, JINAN; HELLSTROM, STEN; ERIKSSON, PER-OLOF
To: OMNIO AB
Reel/Frame 031587/0288 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2013
From: OMNIO AB
To: OMNIO HEALER AB
Reel/Frame 031587/0338 →
Continuity (4)
Continuation 11253972 · Oct 18, 2005
Division 10237144 · Sep 5, 2002
Provisional Application 60317643 · Sep 6, 2001
Related Publication 20080090751A1 · Apr 17, 2008